Status:
ACTIVE_NOT_RECRUITING
New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes
Lead Sponsor:
Prim. Prof. Dr. Oliver Findl, MBA
Conditions:
Epiretinal Membrane
Eligibility:
All Genders
18+ years
Brief Summary
Epiretinal membranes (ERM) are a macular disorder leading to metamorphopsia and a decrease in visual acuity. Peeling of ERM during vitrectomy is, up to date, the only possible treatment option, openin...
Detailed Description
Epiretinal membranes (ERM) are a macular disorder leading to metamorphopsia and a decrease in visual acuity. While ERM are rare among young people, they have prevalence rates of up to 30% in the age g...
Eligibility Criteria
Inclusion
- presence of an idiopathic ERM with decrease in visual acuity affecting activities of the daily life
- undergone pars plana vitrectomy with membrane peeling with application of periocular triamcinolone acetonide and a prolonged application of steroidal eye drops for three months after surgery, performed by a single surgeon in the time period from 01/08/2020 to 31/05/2023.
- presence of a follow-up examination at our department three months after surgery (+-1 month), including OCT with accurate image quality for analyzing the presence or absence of intraretinal cystoid changes and visual acuity testing.
- age of 18 years of older.
Exclusion
- age below 18 years
Key Trial Info
Start Date :
May 16 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT06948851
Start Date
May 16 2024
End Date
April 30 2025
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Institute for Research in Ocular Surgery
Vienna, Austria, 1040